Global Pharma carries the most overweight allocations in Nov – according to BofA’s Global FMS
Investors increased their allocations to pharmaceuticals, banks, and industrials in November, according to the latest BofA ...
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative ...